Skip to main navigation Skip to search Skip to main content

Severity of COVID-19 Pneumonia in Kidney Transplant Recipients According to SARS-CoV-2 Vaccination

  • Seunghyeok Choi
  • , Hanbi Lee
  • , Sang Hun Eum
  • , Ji Won Min
  • , Hye Eun Yoon
  • , Chul Woo Yang
  • , Byung Ha Chung*
  • *Corresponding author for this work
  • The Catholic University of Korea

Research output: Contribution to journalJournal articlepeer-review

Abstract

We reviewed 24 kidney transplantat recipients (KTRs) who had radiologically confirmed coronavirus disease 2019 (COVID-19) pneumonia. Enrolled KTRs were divided into a severe acute respiratory syndrome coronavirus 2 (SARSCoV-2)-vaccination (+) group (n = 18) and a vaccination (-) group (n = 6). Clinical outcomes of the two groups including death, pulmonary outcome, and renal outcome were compared. COVID-19 pneumonia was worse in vaccination (-) KTRs. Two out of six vaccination (-) KTRs needed continuous renal replacement therapy (CRRT) and mechanical ventilator (MV) and expired. In contrast, only one KTR expired and required CRRT and MV out of 18 vaccination (+) KTRs. Our results suggest that SARS-CoV-2 vaccination attenuates severity of COVID-19 pneumonia in KTRs.

Original languageEnglish
Pages (from-to)505-509
Number of pages5
JournalInfection and Chemotherapy
Volume55
Issue number4
DOIs
StatePublished - 2023.12

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COVID-19 pneumonia
  • Kidney transplant recipient
  • SARS-CoV-2 vaccine

Fingerprint

Dive into the research topics of 'Severity of COVID-19 Pneumonia in Kidney Transplant Recipients According to SARS-CoV-2 Vaccination'. Together they form a unique fingerprint.

Cite this